NTRK-REARRANGED SPINDLE CELL NEOPLASM

Clinical trials for NTRK-REARRANGED SPINDLE CELL NEOPLASM explained in plain language.

Never miss a new study

Get alerted when new NTRK-REARRANGED SPINDLE CELL NEOPLASM trials appear

Sign up with your email to follow new studies for NTRK-REARRANGED SPINDLE CELL NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare childhood cancer: drug cocktail aims to shrink tumors and prevent return

Disease control Recruiting now

This study is for children and young adults (up to age 30) with a rare type of soft tissue cancer called non-rhabdomyosarcoma. It tests whether adding the drugs pazopanib and selinexor to standard chemotherapy can improve outcomes. Participants receive treatment tailored to their…

Matched conditions: NTRK-REARRANGED SPINDLE CELL NEOPLASM

Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC

NTRK-REARRANGED SPINDLE CELL NEOPLASM

Get alerted when new NTRK-REARRANGED SPINDLE CELL NEOPLASM trials appear

New hope for rare childhood cancer: drug cocktail aims to shrink tumors and prevent return